Entrada Therapeutics, Inc. Share Price & Technical Analysis
TRDA · $6.83 (+4.12%)
Healthcare / Biotechnology
$6.83
+4.12%
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potenti…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
-51% return in May, 5% avg return in past 3 year May month.
-24% return in 2026, 10% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 12% | 4% | 7% | 5% | -51% | – | – | – | – | – | – | – | -24% |
| 25 | -23% | -8% | -24% | 1% | -16% | -13% | -12% | -5% | 5% | 21% | 49% | 2% | -23% |
| 24 | -3% | -10% | 7% | -17% | 29% | -10% | 15% | 7% | -10% | 8% | 16% | -13% | 17% |
| 23 | -14% | 7% | 15% | -20% | 2% | 32% | 21% | -16% | 7% | 3% | -18% | 15% | 36% |
| 22 | -36% | 10% | -23% | -37% | 15% | 79% | 7% | 1% | 24% | 44% | -34% | -7% | 43% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$279.70M
P/E ratio
—
52W high
$16.45
52W low
$4.93
Volume
41,161
Beta
-0.09
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Entrada Therapeutics, Inc. share price today?
- Entrada Therapeutics, Inc. (TRDA) last traded around $6.83 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TRDA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TRDA. Download the app for real-time alerts.
- How can I analyze Entrada Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.